Reduced Graphene Oxide and Gold Nanoparticles-Modified Electrochemical Aptasensor for Highly Sensitive Detection of Doxorubicin
Open Access
- 30 March 2023
- journal article
- research article
- Published by MDPI AG in Nanomaterials
- Vol. 13 (7) , 1223
Abstract
Doxorubicin (DOX) is the most clinically important antibiotic in cancer treatment, but its severe cardiotoxicity and other side effects limit its clinical use. Therefore, monitoring DOX concentrations during therapy is essential to improve efficacy and reduce adverse effects. Here, we fabricated a sensitive electrochemical aptasensor for DOX detection. The sensor used gold wire as the working electrode and was modified with reduced graphene oxide (rGO)/gold nanoparticles (AuNPs) to improve the sensitivity. An aptamer was used as the recognition element for the DOX. The 5′ end of the aptamer was modified with a thiol group, and thus immobilized to the AuNPs, and the 3′ end was modified with methylene blue, which acts as the electron mediator. The combination between the aptamer and DOX would produce a binding-induced conformation, which changes the electron transfer rate, yielding a current change that correlates with the concentration of DOX. The aptasensor exhibited good linearity in the DOX concentration range of 0.3 μM to 6 μM, with a detection limit of 0.1 μM. In addition, the aptasensor was used for DOX detection in real samples and results, and showed good recovery. The proposed electrochemical aptasensor will provide a sensitive, fast, simple, and reliable new platform for detecting DOX.Keywords
Funding Information
- National Natural Science Foundation of China (T2293731, 62121003, 61960206012, 62171434, 81971348, 61973292, 61975206, 61971400, GJJSTD20210004, 2022YFC2402501, 2021ZD0201603)
- Scientific Instrument Developing Project of the Chinese Academy of Sciences (T2293731, 62121003, 61960206012, 62171434, 81971348, 61973292, 61975206, 61971400, GJJSTD20210004, 2022YFC2402501, 2021ZD0201603)
- National Key R&D Program (T2293731, 62121003, 61960206012, 62171434, 81971348, 61973292, 61975206, 61971400, GJJSTD20210004, 2022YFC2402501, 2021ZD0201603)
- Major Program of Scientific and Technical Innovation 2030 (T2293731, 62121003, 61960206012, 62171434, 81971348, 61973292, 61975206, 61971400, GJJSTD20210004, 2022YFC2402501, 2021ZD0201603)
This publication has 64 references indexed in Scilit:
- Doxorubicin pathwaysPharmacogenetics and Genomics, 2011
- Analysis of intracellular doxorubicin and its metabolites by ultra-high-performance liquid chromatographyJournal of Chromatography B, 2010
- Graphene: Status and ProspectsScience, 2009
- Aptamer-based biosensorsTrAC Trends in Analytical Chemistry, 2008
- Electric Field Effect in Atomically Thin Carbon FilmsScience, 2004
- Simultaneous spectrophotometric determination of rutin, quercetin and ascorbic acid in drugs using a Kalman Filter approachJournal of Pharmaceutical and Biomedical Analysis, 1999
- A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicinBiochemical Pharmacology, 1999
- Therapeutic drug monitoring of doxorubicin in paediatric oncology using capillary electrophoresisElectrophoresis, 1998
- Clinical Pharmacokinetics of DoxorubicinClinical Pharmacokinetics, 1988
- Daunorubicin and doxorubicin, anthracycline antibiotics, a physicochemical and biological reviewBiochimie, 1984